Cochliobolus sativus
Star0
Explore a selection of our essential drug information below, or:
Overview
- Description
- An extract from Cochliobolus sativus used in allergy testing.
- Description
- An extract from Cochliobolus sativus used in allergy testing.
- DrugBank ID
- DB10433
- Type
- Biotech
- Clinical Trials
- Phase 0
- 0
- Phase 1
- 0
- Phase 2
- 0
- Phase 3
- 0
- Phase 4
- 0
Identification
- Summary
Cochliobolus sativus is an extract from Cochliobolus sativus used in allergy testing.
- Generic Name
- Cochliobolus sativus
- DrugBank Accession Number
- DB10433
- Background
Cochliobolus sativus is a fungus which can provoke allergic reactions. Cochliobolus sativus extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Bipolaris sorokiniana Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Bipolaris sorokiniana Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Bipolaris sorokiniana Solution 40000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Bipolaris Sorokiniana Injection, solution 0.05 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Bipolaris sorokiniana Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image A Mold Mixture Cochliobolus sativus (0.0017 g/1mL) + Aspergillus flavus (0.0004 g/1mL) + Aspergillus fumigatus (0.0004 g/1mL) + Aspergillus niger var. niger (0.0004 g/1mL) + Aspergillus repens (0.0004 g/1mL) + Aureobasidium pullulans var. pullutans (0.0017 g/1mL) + Botrytis cinerea (0.0017 g/1mL) + Candida tropicalis (0.0008 g/1mL) + Chaetomium globosum (0.0017 g/1mL) + Epicoccum nigrum (0.0017 g/1mL) + Fusarium oxysporum (0.0017 g/1mL) + Geotrichum candidum (0.0017 g/1mL) + Mucor plumbeus (0.0006 g/1mL) + Mucor racemosus (0.0006 g/1mL) + Neurospora intermedia (0.0008 g/1mL) + Penicillium camemberti (0.0003 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0003 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0003 g/1mL) + Penicillium expansum (0.0003 g/1mL) + Penicillium italicum (0.0003 g/1mL) + Penicillium roqueforti (0.0003 g/1mL) + Phoma destructiva (0.0017 g/1mL) + Rhizopus stolonifer (0.0017 g/1mL) + Rhizopus stolonifer (0.0006 g/1mL) + Rhodotorula rubra (0.0017 g/1mL) + Saccharomyces cerevisiae (0.0017 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US A Mold Mixture Cochliobolus sativus (0.0067 g/1mL) + Aspergillus flavus (0.0017 g/1mL) + Aspergillus fumigatus (0.0017 g/1mL) + Aspergillus niger var. niger (0.0017 g/1mL) + Aspergillus repens (0.0017 g/1mL) + Aureobasidium pullulans var. pullutans (0.0067 g/1mL) + Botrytis cinerea (0.0067 g/1mL) + Candida tropicalis (0.0033 g/1mL) + Chaetomium globosum (0.0067 g/1mL) + Epicoccum nigrum (0.0067 g/1mL) + Fusarium oxysporum (0.0067 g/1mL) + Geotrichum candidum (0.0067 g/1mL) + Mucor plumbeus (0.0022 g/1mL) + Mucor racemosus (0.0022 g/1mL) + Neurospora intermedia (0.0033 g/1mL) + Penicillium camemberti (0.0011 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0011 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0011 g/1mL) + Penicillium expansum (0.0011 g/1mL) + Penicillium italicum (0.0011 g/1mL) + Penicillium roqueforti (0.0011 g/1mL) + Phoma destructiva (0.0067 g/1mL) + Rhizopus stolonifer (0.0067 g/1mL) + Rhizopus stolonifer (0.0022 g/1mL) + Rhodotorula rubra (0.0067 g/1mL) + Saccharomyces cerevisiae (0.0067 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1992-04-13 Not applicable US A Mold Mixture Cochliobolus sativus (0.0033 g/1mL) + Aspergillus flavus (0.0008 g/1mL) + Aspergillus fumigatus (0.0008 g/1mL) + Aspergillus niger var. niger (0.0008 g/1mL) + Aspergillus repens (0.0008 g/1mL) + Aureobasidium pullulans var. pullutans (0.0033 g/1mL) + Botrytis cinerea (0.0033 g/1mL) + Candida tropicalis (0.0017 g/1mL) + Chaetomium globosum (0.0033 g/1mL) + Epicoccum nigrum (0.0033 g/1mL) + Fusarium oxysporum (0.0033 g/1mL) + Geotrichum candidum (0.0033 g/1mL) + Mucor plumbeus (0.0011 g/1mL) + Mucor racemosus (0.0011 g/1mL) + Neurospora intermedia (0.0017 g/1mL) + Penicillium camemberti (0.0006 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0006 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0006 g/1mL) + Penicillium expansum (0.0006 g/1mL) + Penicillium italicum (0.0006 g/1mL) + Penicillium roqueforti (0.0006 g/1mL) + Phoma destructiva (0.0033 g/1mL) + Rhizopus stolonifer (0.0033 g/1mL) + Rhizopus stolonifer (0.0011 g/1mL) + Rhodotorula rubra (0.0033 g/1mL) + Saccharomyces cerevisiae (0.0033 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US AHH Mold Mix Cochliobolus sativus (13333.333 [PNU]/1mL) + Alternaria alternata (13333.333 [PNU]/1mL) + Cladosporium sphaerospermum (13333.333 [PNU]/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US AHH Mold Mix Cochliobolus sativus (0.0166 g/1mL) + Alternaria alternata (0.0166 g/1mL) + Cladosporium sphaerospermum (0.0166 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3LN5B70U4W
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347910602
- 852398
- Wikipedia
- Cochliobolus_sativus
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.01 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 10000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.10 g/1mL Injection, solution Subcutaneous 0.001 g/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 0.025 g/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection, solution Subcutaneous Solution Intradermal; Percutaneous; Subcutaneous Injection, solution Percutaneous; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53